SKU(재고 관리 코드):ELK9589
Human NFKB-p65(Nuclear Factor Kappa B p65) ELISA Kit
Human NFKB-p65(Nuclear Factor Kappa B p65) ELISA Kit
Human NFKB-p65(Nuclear Factor Kappa B p65) ELISA Kit
Overview
Product name: | Human NFKB-p65(Nuclear Factor Kappa B p65) ELISA Kit |
Reactivity: | Human |
Alternative Names: | NFKB3; p65; RelA |
Assay Type: | Sandwich |
Sensitivity: | 0.10 ng/mL |
Standard: | 10 ng/mL |
Detection Range: | 0.16-10 ng/mL |
Sample Type: | serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids |
Assay Length: | 3.5h |
Research Area: | Signal transduction; |
Test principle: | The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Human NFKB-p65. Standards or samples are added to the appropriate microtiter plate wells then with a biotin-conjugated antibody specific to Human NFKB-p65. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Human NFKB-p65, biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Human NFKB-p65 in the samples is then determined by comparing the OD of the samples to the standard curve. |
Standard curve
Concentration (ng/mL) | OD | Corrected OD |
---|---|---|
10.00 | 1.956 | 1.858 |
5.00 | 1.674 | 1.576 |
2.50 | 1.174 | 1.076 |
1.25 | 0.797 | 0.699 |
0.63 | 0.555 | 0.457 |
0.32 | 0.377 | 0.279 |
0.16 | 0.236 | 0.138 |
0.00 | 0.098 | 0.000 |
Precision
Intra-assay Precision (Precision within an assay):CV%<8%
Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-assay Precision (Precision between assays):CV%<10%
Three samples of known concentration were tested in forty separate assays to assess inter-assay precision.
Recovery
Matrices listed below were spiked with certain level of recombinant NFKB-p65 and the recovery rates were calculated by comparing the measured value to the expected amount of NFKB-p65 in samples.
Matrix | Recovery range | Average |
---|---|---|
serum(n=5) | 96-107% | 101% |
EDTA plasma(n=5) | 79-93% | 86% |
Heparin plasma(n=5) | 80-97% | 88% |
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of NFKB-p65 and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
Matrix | 1:2 | 1:4 | 1:8 | 1:16 |
---|---|---|---|---|
serum(n=5) | 89-98% | 95-103% | 99-106% | 78-92% |
EDTA plasma(n=5) | 82-96% | 87-103% | 91-97% | 81-93% |
Heparin plasma(n=5) | 78-91% | 87-98% | 92-101% | 96-105% |